Table 1.
Characteristics | Control Group (n = 50) | PC Group (n = 50) | Significance | ||
---|---|---|---|---|---|
Mean (SD) | Group Size | Mean (SD) | Group Size | p-Value | |
Age (years) | 63.30 (9.61) | 50 | 70.00 (8.98) | 50 | <0.0001 |
Prostate volume (mL) | 26.24 (8.77) | 24 | 39.77(19.00) | 50 | 0.0169 |
PSA (≤ 10 ng/mL) | 1.56 (0.89) | 50 | 6.69 (1.96) | 14 | |
PSA (10.1–20 ng/mL) | NA | 0 | 14.01 (2.08) | 14 | |
PSA (> 20 ng/mL) | NA | 0 | 89.82 (86.28) | 22 | |
GS (pre) 6 | NA | NA | NA | 13 | |
GS (pre) ≥7 | NA | NA | NA | 34 | |
GS (post) 6 | NA | NA | NA | 6 | |
GS (post) ≥7 | NA | NA | NA | 35 | |
Treatment: | 50 | ||||
Radical operation | 41 | ||||
Seed implantation | 5 | ||||
Endocrine | 2 | ||||
Chemotherapy | 1 | ||||
TURP | 1 |
GS = Gleason Score; GS (pre) = GS of biopsy; 41 patients have accepted radical operation and got the post-operation GS (GS (post)); SD = standard deviation; prostate volume was calculated as volume: volume (mL) = (length × width × height) × π/6. TURP = Transurethral resection of the prostate; NA = not applicable; PC = prostate cancer.